Chiun‐Sheng Huang - Publications, H-index & Citations

Chiun‐Sheng Huang

department of surgery

65H指数

555论文数

2.8W被引数

收录论文 199

发表时间

Breast Cancer Recurrence Status Assessment in 5 Years Using Multimodal Integrated Learning: A Feasibility Study 利用多模态集成学习评估5年内乳腺癌复发状态：一项可行性研究

Journal of Digital Imaging

IF3.8

2026-09-08

PREAI

Ruey-Feng Chang; Hsiang-Wei Huang; Szu-Yen Kuo; Yan-Wei Lee; Ming-Yang Wang; Chiun-Sheng Huang

The moderating and mediating effects of mindful compassion with body-mind-spirit therapy using a blended approach of face-to-face with online for breast cancer patients' depression during COVID-19: A randomized controlled trial 新冠疫情期间面对面与在线混合式身心灵疗法中正念慈悲的调节与中介效应及其对乳腺癌患者抑郁的影响：一项随机对照试验

Internet Interventions

IF0

2026-04-21

OAAI

Fei-Hsiu Hsiao; Chiao Lo; Wen-Hung Kuo; Chia-Chen Hsieh; Chiun-Sheng Huang

Response to comments on “Reassessing regional nodal radiotherapy strategies for breast cancer in the context of modern systemic treatments.”对“在现代化全身治疗背景下重新评估乳腺癌区域淋巴结放射治疗策略”的评论回复

Journal of the Formosan Medical Association

IF2.5

2026-04-21

OAAI

Wen-Chi Yang; Yu-Hsuan Chen; Shih-Fan Lai; Chia-Chun Wang; Sung-Hsin Kuo; Chiun-Sheng Huang

The influence of immunohistochemistry-based subtypes on overall survival in breast cancer spine metastases: a systematic review and meta-analysis 免疫组化分型对乳腺癌脊柱转移患者总生存期的影响：一项系统评价和荟萃分析

BMC Medicine

IF8.3

2026-02-21

OAAI

Fon-Yih Tsuang; Yun-Heng Li; Ting-Li Shen; Chiun-Sheng Huang; Chung Liang Chai

ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant Therapy 林佩慧；蔡立薇；罗诚；郭淑惠；倪慈慈；于慈慧；黄慈顺。HER2阳性乳腺癌新辅助治疗后检测到的循环肿瘤DNA与较差预后相关，并可指导辅助治疗。癌症研究通讯。2026, 6, 105–114. [谷歌学术] [CrossRef] [PubMed]

Cancer Research Communications

IF0

2026-01-01

PREAI

Lin, Po-Han; Tsai, Li-Wei; Lo, Chiao; Kuo, Sung-Hsin; Ni, Chia-Chun; Yu, Chih-Hao; Huang, Chiun-Sheng

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial Imlunestrant与或不与Abemaciclib联用治疗晚期乳腺癌：来自Ⅲ期EMBER-3试验的更新疗效结果

Annals of Oncology

IF65.4

2025-12-12

OAAI

K.L. Jhaveri; P. Neven; M.L. Casalnuovo; S-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; J. O’Shaughnessy; N. Harbeck; L.A. Carey; G. Curigliano; J. Watanabe; E. Lim; J. Huang; Z. Qingyuan; A. Llombart-Cussac; C. Huang; B. Desai; Y. Limay; X.A. Wang

Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer 曲妥珠单抗Deruxtecan在早期乳腺癌残留HER2-Positive中的应用

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-12-01

PREAI

Loibl, Sibylle; Park, Yeon Hee; Shao, Zhiming; Huang, Chiun-Sheng; Barrios, Carlos; Abraham, Jame; Prat, Aleix; Niikura, Naoki; Im, Seock-Ah; Li, Wei; Li, Huiping; Wang, Yongsheng; Yao, Herui; Kim, Sung-Bae; Geng, Cui-zhi; Rodriguez Pantigoso, Wuilbert; Ramirez Godinez, Francisco Javier; Song, Chuangui; Ching Chang, Yuan; Antoniazzi, Augusto; Chen, Shin-Cheh; Li, Zhigao; Nowecki, Zbigniew; Lim, Joline; Mathias, Elton; Sato, Yuta; Lu, Wenjing; Abdel-Monem, Hanan; Untch, Michael; Geyer, Charles E.

Prognostic factors for early-stage triple-negative breast cancer with a focus on neutrophil-to-lymphocyte ratio: A single-center retrospective study 早期三阴性乳腺癌的预后因素：基于中性粒细胞与淋巴细胞比值的单中心回顾性研究

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY

IF2.2

2025-11-01

OAAI

Lee, Yu-Kwang; Hsu, Chen-Yang; Wang, Ming-Yang; Kuo, Wen-Hung; Lien, Huang-Chun; Lee, Yi-Hsuan; Lo, Chiao; Huang, Chiun-Sheng

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆HR阳性/HER2阴性早期乳腺癌患者的辅助瑞博西lib联合非甾体类芳香化酶抑制剂治疗：NATALEE试验5年随访的有效性结局及更新后的总生存期☆

ESMO Open

IF8.3

2025-10-17

OAAI

J. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi

Overall Survival with Abemaciclib in Early Breast Cancer 早期乳腺癌中使用Abemaciclib的总体生存率

Annals of Oncology

IF65.4

2025-10-17

OAAI

S. Johnston; M. Martin; J. O’Shaughnessy; R. Hegg; S.M. Tolaney; V. Guarneri; L. Del Mastro; M. Campone; J. Sohn; F. Boyle; J. Cortes; H.S. Rugo; M.P. Goetz; E.P. Hamilton; C-S. Huang; E. Senkus; I. Cicin; L. Testa; P. Neven; J. Huober; Z. Shao; R. Wei; M. Munoz; B. San Antonio; A. Shahir; P. Rastogi; N. Harbeck

Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 肿瘤特异性主要组织相容性-II表达预测三阴性乳腺癌中阿替利珠单抗联合化疗的病理完全缓解

npj Breast Cancer

IF7.6

2025-09-29

OAAI

Justin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini

Evaluation of cardiotoxicity following breast cancer irradiation in an Asian cohort in real-world settings 亚洲人群乳腺癌放疗后心脏毒性评估的真实世界研究

The Breast

IF0

2025-09-17

OAAI

Wen-Chi Yang; Yu-Hsuan Chen; Chia-Chun Wang; Shih-Fan Lai; Szu-Huai Lu; Li-Ting Ho; Chiun-Sheng Huang; Sung-Hsin Kuo

Characterization of the tumor immune microenvironment in pregnancy-associated breast cancer through multiplex immunohistochemistry and transcriptome analyses 通过多重免疫组化和转录组分析对妊娠相关乳腺癌肿瘤免疫微环境进行表征

Breast Cancer Research

IF5.6

2025-08-29

OAAI

Ching-Hsuan Chen; I-Chun Chen; Chia-Lang Hsu; Tzu-Pin Lu; Ming-Yang Wang; Li-Wei Tsai; Chiun-Sheng Huang; Yen-Shen Lu; Ching-Hung Lin

Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis 循环肿瘤DNA在早期三阴性乳腺癌中的作用：一项系统评价和Meta分析

BREAST CANCER RESEARCH

IF5.6

2025-03-12

OAAI

Zhang, Diana; Jahanfar, Shayesteh; Rabinowitz, Judy B.; Dower, Joshua; Song, Fei; Wu, Cherng-Horng; Hu, Xiao; Tracy, Phillip; Basik, Mark; Medford, Arielle; Lin, Po-Han; Huang, Chiun-Sheng; Bidard, Francois-Clement; Renault, Shufang; Pai, Lori; Buss, Mary; Parsons, Heather A.; Schlam, Ilana

Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study T1cN0M0和选择性T1bN0M0三阴性乳腺癌辅助化疗的获益：一项基于全国癌症登记的研究

ONCOLOGIST

IF4.2

2025-03-05

PREAI

Lo, Chiao; Chang, Dwan-Ying; Lu, Yen-Shen; Wang, Ming-Yang; Tsai, Li-Wei; Huang, Chiun-Sheng; Tang, Chao-Hsiun; Lin, Ching-Hung

Reassessing regional nodal radiotherapy strategies for breast cancer in the context of modern systemic treatments 重新评估现代全身治疗背景下乳腺癌区域性淋巴结放疗策略

Journal of the Formosan Medical Association

IF2.5

2025-02-15

OAAI

Wen-Chi Yang; Yu-Hsuan Chen; Shih-Fan Lai; Chia-Chun Wang; Sung-Hsin Kuo; Chiun-Sheng Huang

Analysis of Asian and non-Asian patients (pts) from the NATALEE trial of ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) in pts with HR+/HER2L early breast cancer (EBC)亚洲和非亚洲患者(pts)在NATALEE试验中，接受ribociclib(RIB)联合非甾体类芳香化酶抑制剂(NSAI)治疗人表皮生长因子受体2低表达激素受体阳性早期乳腺癌(EBC)的分析

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Xu, B.; Stroyakovskiy, D.; Sohn, J.; Park, Y. H.; Huang, C-S.; Lu, Y-S.; Jung, K. H.; Chan, A.; Zhang, J.; Lee, J.; Kim, J. H.; Chung, C-F.; Slamon, D.; Sakalosh, V.; Gao, M.; Amin, K.; Islam, S.; Im, S-A.

Real-world treatment patterns and survival outcomes in patients (pts) with HER2+unresectable (u) or metastatic breast cancer (mBC): HER2 REAL Asia cohort HER2阳性不可切除（u）或转移性乳腺癌（mBC）患者的真实世界治疗模式与生存结局：HER2 REAL Asia队列

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Lee, S. C.; Chung, W-P.; Ngan, R. K. C.; Im, S-A.; Hui, R.; Kim, S-B; Huang, C-S.; Tung, T.

Clinical characteristics of patients (pts) with HER2+unresectable (u) or metastatic (m) breast cancer (BC): HER2 REAL Asia cohort HER2阳性不可切除（u）或转移性（m）乳腺癌（BC）患者的临床特征：HER2 REAL Asia队列

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Lee, S. C.; Chung, W-P.; Ngan, K. C. R.; Im, S-A.; Hui, R.; Kim, S-B.; Huang, C-S.; Tung, T.